LIFECORE BIOMEDICAL, INC. Income (Loss) from Continuing Operations, Per Basic Share
LIFECORE BIOMEDICAL, INC. (LFCR) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.54 per share for the 7-month period ending 2025-12-31, per its 10-KT filed 2026-03-16.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2026-03-16
- LIFECORE BIOMEDICAL, INC. income (loss) from continuing operations, per basic share for the quarter ending 2025-02-23 was -$0.47, a 197.92% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. income (loss) from continuing operations, per basic share for the quarter ending 2024-11-24 was -$0.25, a 153.19% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. income (loss) from continuing operations, per basic share for the quarter ending 2024-08-25 was -$0.53.
- LIFECORE BIOMEDICAL, INC. income (loss) from continuing operations, per basic share for the quarter ending 2024-02-25 was $0.48.
- LIFECORE BIOMEDICAL, INC. income (loss) from continuing operations, per basic share for fiscal 2025 was -$1.27, a 523.33% decline from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. income (loss) from continuing operations, per basic share for fiscal 2024 was $0.30.
- LIFECORE BIOMEDICAL, INC. income (loss) from continuing operations, per basic share for fiscal 2023 was -$2.14.
- LIFECORE BIOMEDICAL, INC. income (loss) from continuing operations, per basic share for fiscal 2022 was -$0.53.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 7 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 12 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$0.54 10-KT · filed 2026-03-16 | ||||||||
| 2025-05-25 | -$1.27 10-KT · filed 2026-03-16 | ||||||||
| 2025-02-23 | -$0.47 10-Q · filed 2025-04-03 | -$1.24 10-Q · filed 2025-04-03 | |||||||
| 2024-11-24 | -$0.25 10-Q · filed 2025-01-02 | -$0.76 10-Q · filed 2025-01-02 | |||||||
| 2024-08-25 | -$0.53 10-Q · filed 2024-10-04 | ||||||||
| 2024-05-26 | $0.30 10-KT · filed 2026-03-16 | $0.31 10-K · filed 2024-08-26 | |||||||
| 2024-02-25 | $0.48 10-Q · filed 2025-04-03 | $0.54 10-Q · filed 2025-04-03 | |||||||
| 2023-11-26 | $0.47 10-Q · filed 2025-01-02 | $0.05 10-Q · filed 2025-01-02 | |||||||
| 2023-08-27 | -$0.41 10-Q · filed 2024-10-04 | ||||||||
| 2023-05-28 | -$1.23 10-K · filed 2024-03-20 | -$2.14 10-K · filed 2024-08-26 | |||||||
| 2023-02-26 | -$0.37 10-Q · filed 2024-08-09 | -$0.51 10-Q · filed 2023-06-02 | -$0.91 10-Q · filed 2024-08-09 | -$1.16 10-Q · filed 2023-06-02 | |||||
| 2022-11-27 | -$0.31 10-Q · filed 2024-08-09 | -$0.42 10-Q · filed 2023-03-16 | -$0.54 10-Q · filed 2024-08-09 | -$0.80 10-Q · filed 2023-03-16 | |||||
| 2022-08-28 | -$0.23 10-Q · filed 2024-08-09 | -$0.41 10-Q · filed 2022-10-07 | |||||||
| 2022-05-29 | -$0.12 10-K · filed 2024-03-20 | -$1.16 10-K · filed 2022-09-14 | -$0.53 10-K · filed 2024-08-26 | -$1.57 10-K · filed 2022-09-14 | |||||
| 2022-02-27 | -$0.37 10-K · filed 2024-03-20 | -$0.28 10-K · filed 2022-09-14 | -$0.39 10-Q · filed 2023-06-02 | -$0.41 10-K · filed 2022-09-14 | |||||
| 2021-11-28 | $0.25 10-K · filed 2024-03-20 | $0.12 10-K · filed 2022-09-14 | -$0.12 10-Q · filed 2023-03-16 | ||||||
| 2021-08-29 | -$0.29 10-K · filed 2024-03-20 | -$0.25 10-K · filed 2022-09-14 | |||||||
| 2021-05-30 | -$0.03 10-K/A · filed 2023-03-16 | -$0.14 10-K · filed 2021-07-29 | -$0.80 10-K · filed 2024-03-20 | -$1.12 10-K · filed 2021-07-29 | |||||
| 2021-02-28 | -$0.06 10-K · filed 2024-03-20 | -$0.19 10-K · filed 2021-07-29 | |||||||
| 2020-11-29 | -$0.29 10-K · filed 2024-03-20 | -$0.45 10-K · filed 2021-07-29 | |||||||
| 2020-08-30 | -$0.34 10-K · filed 2024-03-20 | -$0.38 10-K · filed 2021-07-29 | |||||||
| 2020-05-31 | -$0.52 10-K · filed 2021-07-29 | -$0.75 10-K/A · filed 2023-03-16 | -$1.31 10-K · filed 2020-08-14 | ||||||
| 2020-02-23 | -$0.39 10-K · filed 2021-07-29 | -$0.79 10-Q · filed 2020-04-03 | |||||||
| 2019-11-24 | -$0.23 10-K · filed 2021-07-29 | -$0.40 10-Q · filed 2020-01-02 | |||||||
| 2019-08-25 | -$0.16 10-K · filed 2021-07-29 | ||||||||
| 2019-05-26 | $0.01 10-K · filed 2020-08-14 | $0.07 10-K · filed 2021-07-29 | |||||||
| 2019-02-24 | $0.05 10-K · filed 2020-08-14 | $0.04 10-Q · filed 2019-04-04 | $0.06 10-Q · filed 2020-04-03 | $0.02 10-Q · filed 2019-04-04 | |||||
| 2018-11-25 | $0.00 10-K · filed 2020-08-14 | -$0.02 10-Q · filed 2019-01-07 | $0.01 10-Q · filed 2020-01-02 | -$0.01 10-Q · filed 2019-01-07 | |||||
| 2018-08-26 | $0.01 10-K · filed 2020-08-14 | ||||||||
| 2018-05-27 | $0.24 10-K · filed 2019-08-01 | $0.93 10-K · filed 2020-08-14 | |||||||
| 2018-02-25 | $0.59 10-K · filed 2019-08-01 | $0.69 10-Q · filed 2019-04-04 | |||||||
| 2017-11-26 | $0.02 10-K · filed 2019-08-01 | $0.10 10-Q · filed 2019-01-07 | |||||||
| 2017-08-27 | $0.08 10-K · filed 2019-08-01 | ||||||||
| 2017-05-28 | $0.09 10-K · filed 2018-08-09 | $0.37 10-K · filed 2019-08-01 | |||||||
| 2017-02-26 | $0.13 10-K · filed 2018-08-09 | ||||||||
| 2016-11-27 | $0.03 10-K · filed 2018-08-09 | ||||||||
| 2016-08-28 | $0.12 10-K · filed 2018-08-09 | ||||||||
| 2016-05-29 | -$0.45 10-K · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |